Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.780
-0.040 (-2.20%)
At close: Sep 26, 2025, 4:00 PM EDT
1.820
+0.040 (2.25%)
After-hours: Sep 26, 2025, 4:00 PM EDT
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$81,987
Profits / Employee
-$298,797
Market Cap
174.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IPHA News
- 10 days ago - Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Innate Pharma Reports First Half 2025 Business Update and Financial Results - Business Wire
- 13 days ago - Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event - Business Wire
- 17 days ago - Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update - Business Wire
- 2 months ago - Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference - Business Wire
- 3 months ago - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences - Business Wire
- 3 months ago - Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress - Business Wire
- 4 months ago - Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences - Business Wire